Emcure Pharmaceuticals Limited has informed the Exchange about Acquisition
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals is acquiring at least 26% stake in Torrent Urja 37 Private Limited (TUPL), a wholly owned subsidiary of Torrent Green Energy Private Limited, for a cash consideration of about Rs. 3.72 crore. TUPL is setting up an 11.27 MWp ground-mounted solar power plant in Gujarat, which will serve as a captive power facility for Emcure's operations in the state under two Power Transfer Agreements signed on June 2, 2025. The deal involves a Share Subscription and Shareholders' Agreement, making it a structured partnership rather than a plain minority investment, though Emcure clarifies it is not a related-party transaction. The target is newly incorporated (January 2025) and has no turnover history yet, and completion is subject to regulatory open-access approvals for captive electricity consumption. This is a strategic move by the pharma company into renewable energy to secure captive, cost-effective green power for its Gujarat facilities.
Small in scale financially (Rs. 3.72 crore), but strategically meaningful as it locks in long-term renewable power for Emcure's Gujarat plants, potentially reducing energy costs and supporting ESG goals. Likely neutral to mildly positive for the stock in the short term.